v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (17,348,217) $ (7,903,950)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of derivative liability 1,268,162
Loss on settlement of derivative liability 3,881,922
Loss on exchange transaction 2,215,127
Depreciation 1,109,213 144,685
Amortization 502,272 62,510
Bad debt expense 3,025,000
Amortization of debt issuance costs 1,963,579 840,845
Amortization of right of use asset 20,478 1,687
Stock based compensation 177,011
Impairment of intangible assets 965,812
Loss on sale of equipment 80,289
Common stock for services 178,558
Changes in operating assets and liabilities:    
Account receivable (548,312) (168,831)
Inventory 281,969 (30,412)
Prepaid assets and other current assets (823,075) 346,551
Notes receivable 2,500
Due to affiliates (47,455) 204,219
Accounts payable and accrued expenses 2,183,303 2,409,973
Operating lease liabilities (21,720) (1,687)
Net cash (used in) provided by operating activities (5,103,907) 75,913
Cash flows from investing activities:    
Additions to intangible assets (7,778)
Cash received in acquisition 309,557
Purchase of CIP materials (2,575)
Proceeds from sale of property and equipment 25,000
Purchase of property and equipment (1,746,796)
Additions to equity based investments (21,300)
Net cash (used in) provided by investing activities (1,743,096) 299,204
Cash flows from financing activities:    
Debt issuance costs (2,068,717) (361,477)
Payments on finance lease (90,640) (13,620)
Cash paid from split (58)
Proceeds from notes payable 16,323,308 1,224,900
Principal payments on debt (2,441,537) (1,339,283)
Cash payment of derivative liability (2,769,189)
Net cash provided by (used in) financing activities 8,953,225 (489,538)
Net change in cash from continuing operations 2,106,222 (114,421)
Net cash provided by (used in) discontinued operations:    
Cash provided by operating activities 237,505
Cash provided by investing activities 59,591
Cash used in financing activities (7,355)
Net cash provided by discontinued operations 289,741
Net change in cash 2,106,222 175,320
Cash – beginning of period 54,066 227,766
Cash – end of period 2,160,288 403,086
Supplemental disclosure of non-cash operating activities:    
Forgiveness of related party accounts payable and accrued expenses 490,000
Issuance of stock for derivative liability settlement 3,592,954
Issuance of stock for warrant exercise 135
Conversion of Series A preferred stock to common stock 272
Conversion of notes payable and accounts payable and accrued expenses for Series C preferred stock and warrants 7,169,072
Deferred gain on sale from sale of equity investment
Forgiveness of amounts due from affiliates 391,524
Issuance of warrants for debt issuance 6,350,209 285,397
Conversion of notes payable 1,450,000
Pre-funded warrants $ 83